Skip to main content
. 2024 Mar 12;61(6):503–519. doi: 10.1136/jmg-2023-109438

Table 1.

Main clinical findings in percentages of individuals with molecularly confirmed Rubinstein-Taybi syndrome

HPO ID* CREBBP (n=308) EP300 (n=52)
Growth
Intrauterine growth retardation 0001511 49 42
Postnatal growth retardation 0004322 75 66
Obesity 0001513 29 39
Microcephaly 0000252 54 87
Craniofacial features
Highly arched eyebrows 0002253 85 65
Long eyelashes 0000527 89 90
Epicanthal folds 0000286 44 15
Strabismus 0000486 71 39
Myopia 0000545 56 24
Downslanted palpebral fissures 0000494 79 56
Convex nasal ridge 0000444 81 44
Columella below alae nasi 0009765 88 92
Typical smile† 0000273 94 47
Highly arched palate 0002705 77 67
Talon cusps‡ 0011087 73 4
Micrognathia 0000347 61 42
Low-set ears 0000369 44 27
Trunk and limbs
Broad thumbs 0011304 96 69
Angulated thumbs § 49 2
Broad finger tips 0011300 87 22
Broad halluces 0010055 95 81
Hypertrichosis 0000998 76 51
Keloids 0010562 23 10
Scoliosis 0002650 18 25
Cardiovascular anomalies 0002564 35 26
Constipation 0002019 76 54
Urinary tract anomalies 0000079 28 24
Neuromuscular
Seizures 0001250 25 10
Cognition and behaviour
Intellectual disability (any degree) 0001249 99 94
Autism/autism spectrum disorder 0000729 49 25

*HPO ID, Human Phenotype Ontology Identifier.

†Smile characterized by crescent-moon shaped palpebral fissures, deepening of labionasal folds, upturned corners of the mouth, usually mouth almost closed, tight upper vermillion and pouting lower vermillion.

‡Permanent dentition.

§No HPO identifier available; we used as definition: angulation of the distal phalanx of a thumb towards the anterior axis (radial side) of the limb.